Torrent Pharma Acquires Unichem Labs India Business
Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.
Magnetic Biocompatible Photonic Crystals can be used both for Optics and Medicine
Researchers at ITMO University developed a new approach for obtaining non-toxic magnetic photonic crystals, expanding their applications from mainly photonics to biomedicine. Nanospheres made with the new method may be used for designing drugs to fight thrombosis and cancer.
Clinical Trial Services and High-Potency Compounds
Capsugel, now a Lonza company, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products utilizing liquid-filled hard capsule (LFHC) technology, at its Edinburgh facility in Scotland.
Radiant 2-dimensional carbon nitride nanomaterials
2-dimesional nanomaterials that could be used to create light emitting diodes (LEDs) or solar cells have been made through the simple, but unconventional, method of spontaneous dissolution.
Fosun Pharmaceutical to buy French drug distributor Tridem
Fosun Pharmaceutical to buy French drug distributor Tridem. The pharmaceuticals arm of Chinese conglomerate Fosun International has agreed to buy Tridem, an Africa-focused French drug distributor, for up to €63m ($73.1m).
Novartis plans acquisition of Advanced Accelerator Applications
Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender offer for 100% of the share capital of AAA subject to certain conditions. Advanced Accelerator Applications (NASDAQ:AAAP) is a radiopharmaceutical company that develops, produces and commercializes Molecular Nuclear Medicines including Lutathera®
AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain. The US Food and Drug Administration (FDA) has granted priority review to AbbVie’s investigational candidate, elagolix, for the management of endometriosis with associated pain. Endometriosis is characterised by long-term pelvic pain and caused by tissue growth outside of the uterus.
Columbia Machine Introduces New Palletizer Machine
Columbia Machine’s HL9200 is the most advanced and highest speed palletizer in Columbia’s high level, high speed family of palletizers. The HL9200 incorporates industry-leading safety package, ultimate flexibility and highest performance levels available in a robust and reliable palletizer that is easy to operate.
Delta expands EtherCAT product offering
Delta expands its EtherCAT product offering to include Remote IO modules. As a major provider of Industrial Automation (IA) product technology, and a key contributor to the global advancement of smarter & greener manufacturing – Delta has released its R1-EC series remote IO modules.
Controlling Air Pollution and Emissions
Mesa supports clean air initiatives and offers various types of equipment that uses BGI pioneering technology to meet and exceed the requirements for ambient particulate sampling dictated by the U.S Environmental Protection Agency.
EtherCAT Motion Control Products
As a major provider of Industrial Automation (IA) product technology, and a key contributor to the global advancement of smarter & greener manufacturing – Delta has released its R1-EC series remote I/O modules. Delta has a continued focus on expanding the EtherCAT Motion Control Products offering.
Shingrix Reaches US Approval
GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.
